anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Resolution

Beat collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 42,534
Current window 28,861-28,890
Pages 1,418
Rows per page 30
Beat: Resolutionclear collectionreset all
18 30 60

Beat

28,861-28,890 of 42,534

filter-aware
11
The slide uses a hub-and-spoke style layout to categorize strategic initiatives under two main pillars.argenx SE | Investor Presentation Deck | 23 slides · argenx
Conference presentation Investor relations Beat · New BlissLoop · Cost Of Inaction1 hit
12
The slide uses a hub-and-spoke visual metaphor to connect the 'Pioneer FcRn class of medicines' to a list of specific autoantibodies.argenx SE | Investor Presentation Deck | 23 slides · argenx
Conference presentation Investor relations Beat · New BlissLoop · Cost Of Inaction1 hit
13
The slide uses a pyramid layout to represent market size, with smaller patient populations at the top and larger ones at the bottom.argenx SE | Investor Presentation Deck | 23 slides · argenx
Conference presentation Investor relations Beat · New BlissLoop · Cost Of Inaction1 hit
14
The slide uses a timeline-based layout to map clinical development stages (Late Stage vs Proof-of-Concept) against expected data readout years (2023, 2024, 2025+).argenx SE | Investor Presentation Deck | 23 slides · argenx
Conference presentation Investor relations Beat · New BlissLoop · Cost Of Inaction1 hit
15
The slide highlights the mechanism of action (sweeping antibody) and the clinical pipeline strategy for ARGX-117.argenx SE | Investor Presentation Deck | 23 slides · argenx
Conference presentation Investor relations Beat · New BlissLoop · Quick Win Big Bet1 hit
16
Includes immunofluorescence microscopy images and bar charts/traces for tidal volume and respiratory rate.argenx SE | Investor Presentation Deck | 23 slides · argenx
Conference presentation Investor relations Beat · New BlissLoop · Quick Win Big Bet1 hit
17
The slide uses a process diagram to show the progression from healthy volunteer studies to patient trials.argenx SE | Investor Presentation Deck | 23 slides · argenx
Conference presentation Investor relations Beat · New BlissLoop · Quick Win Big Bet1 hit
18
The slide uses a circular diagram to represent four distinct business segments.argenx SE | Investor Presentation Deck | 23 slides · argenx
Conference presentation Investor relations Beat · New BlissLoop · Quick Win Big Bet1 hit
19
The slide uses a network-like background to suggest connectivity between the entities shown.argenx SE | Investor Presentation Deck | 23 slides · argenx
Conference presentation Investor relations Beat · New BlissLoop · Quick Win Big Bet1 hit
20
The slide uses a timeline-like structure to map specific drug development and commercialization events to their expected quarters in 2023.argenx SE | Investor Presentation Deck | 23 slides · argenx
Conference presentation Investor relations Beat · New BlissLoop · Quick Win Big Bet1 hit
21
The diagram features five core values: Co-Creation, Empowerment, Excellence, Humility, and Innovation.argenx SE | Investor Presentation Deck | 23 slides · argenx
Conference presentation Investor relations Beat · New Bliss1 hit
22
The chart uses a horizontal bar format to represent clinical development stages (Preclinical to Commercial) for multiple indications under three main programs (VYVGART, ARGX-117, ARGX-119).argenx SE | Investor Presentation Deck | 23 slides · argenx
Conference presentation Investor relations Beat · New Bliss1 hit
23
The slide outlines a multi-stage clinical trial process including patient identification, open-label, and placebo-controlled phases.argenx SE | Investor Presentation Deck | 23 slides · argenx
Conference presentation Investor relations Beat · New Bliss1 hit
27
Aston Martin Lagonda | Results Presentation Deck | 34 slidesAston Martin Lagonda | Results Presentation Deck | 34 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Action1 hit
28
Aston Martin Lagonda | Results Presentation Deck | 34 slidesAston Martin Lagonda | Results Presentation Deck | 34 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Action1 hit
29
Includes footnotes regarding APMs, EPS dilution, and cash availability.Aston Martin Lagonda | Results Presentation Deck | 34 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Action1 hit
30
Contains three distinct tables: Income Statement, Cash Flow, and APM reconciliation.Aston Martin Lagonda | Results Presentation Deck | 34 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Action1 hit
31
The chart displays currency conversion rates (GBP:USD) for each period above the bars.Aston Martin Lagonda | Results Presentation Deck | 34 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Action1 hit
32
Aston Martin Lagonda | Results Presentation Deck | 34 slidesAston Martin Lagonda | Results Presentation Deck | 34 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Action1 hit
33
Aston Martin Lagonda | Results Presentation Deck | 34 slidesAston Martin Lagonda | Results Presentation Deck | 34 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Action1 hit
34
Aston Martin Lagonda | Results Presentation Deck | 34 slidesAston Martin Lagonda | Results Presentation Deck | 34 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Action1 hit
29
Includes footnotes explaining specific adjustments and accounting treatments.UBS | Results Presentation Deck | 37 slides · UBS
Conference presentation Investor relations Beat · Action1 hit
30
The slide uses a bar chart to show revenue trends and a table for 4Q22 financial KPIs, with a detailed disclaimer regarding allocation methodology.UBS | Results Presentation Deck | 37 slides · UBS
Conference presentation Investor relations Beat · Action1 hit
31
Includes a disclaimer regarding allocation methodology and exclusions.UBS | Results Presentation Deck | 37 slides · UBS
Conference presentation Investor relations Beat · Action1 hit
32
The slide uses a waterfall-style comparison for profit before tax and a summary table for operational KPIs.UBS | Results Presentation Deck | 37 slides · UBS
Conference presentation Investor relations Beat · Action1 hit
33
The slide uses a combination of bar charts for profit trends and a summary table for operational KPIs.UBS | Results Presentation Deck | 37 slides · UBS
Conference presentation Investor relations Beat · Action1 hit
34
The slide uses stacked bar charts to illustrate capital components and their corresponding regulatory buffers.UBS | Results Presentation Deck | 37 slides · UBS
Conference presentation Investor relations Beat · Action1 hit
35
The chart uses a standard waterfall bridge to explain the change from 310.6bn to 319.6bn.UBS | Results Presentation Deck | 37 slides · UBS
Conference presentation Investor relations Beat · Action1 hit
36
Uses a waterfall chart to illustrate the RWA pipeline components.UBS | Results Presentation Deck | 37 slides · UBS
Conference presentation Investor relations Beat · Action1 hit
37
UBS | Results Presentation Deck | 37 slidesUBS | Results Presentation Deck | 37 slides · UBS
Conference presentation Investor relations Beat · Action1 hit